Citigroup’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
Citigroup's TECH Position: Q3 2026 in Review
Citigroup increased its Bio-Techne (TECH) stake by 295% in Q3 2026, buying an estimated $94.7M and bringing the position to 1,760,388 shares worth $128M. The position accounts for 0.04% of the portfolio, ranked #414.
Citigroup first reported a position in TECH in Q2 2013 and has held it in 54 quarters since. 586 funds tracked by Wall St. Rank hold TECH as of Q3 2026.
- Citigroup held 1,760,388 shares of Bio-Techne worth $128M as of Q3 2026.
- Citigroup bought 1,315,243 Bio-Techne shares in Q3 2026, an estimated $94.7M.
- Bio-Techne made up 0.04% of Citigroup's portfolio in Q3 2026, its #414 holding.
- Citigroup first reported a position in Bio-Techne in Q2 2013 and has held it in 54 quarters since.
- 586 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.